Figure 1 | Scientific Reports

Figure 1

From: Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR

Figure 1

Summary of the neutralization potency of HCV antibodies against recombinant viruses in HIV/HCV-coinfected patients, at baseline and 24 weeks after sustained virological response. Individual (circles) and median values (short horizontal bars) are represented. Abbreviations: AUC, area under the curve (arbitrary units); ID50, 50% inhibitory dose; SVR, sustained virological response; Wk, week. Statistics: p-values were calculated by the Wilcoxon test.

Back to article page